Doug Barry appointed as Tango Therapeutics’ new general counsel
Tango Therapeutics, a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, has appointed Doug Barry (pictured) as general counsel.
Doug Barry bring to Tango Therapeutics more than 20 years of legal experience. He joins Tango from Alexion Pharmaceuticals, where he was vice president of corporate law, and was responsible for public reporting, corporate governance, financing transactions, and litigation. Prior to that, he was associate general counsel at Alere, Earlier in his career, Barry served as counsel for GT Solar and for Sophos. He practiced law for 9 years as an attorney in the corporate department at WilmerHale.